Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - NET INCOME
Net Income ITCI - Intra-Cellular Therapies, Inc.
-140 M
LAST VALUE
29.89%
2 YEAR CAGR
2.08%
5 YEAR CAGR
-17.92%
10 YEAR CAGR